Michael McNamara, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Targeted Therapy
Case Western Reserve University School of Medicine
Medical School
University of Pittsburgh Medical Center
Residency
University of Pittsburgh Medical Center
Fellowship
American Board of Internal Medicine - Oncology
OH State Medical License Active through 2018
CLEVELAND CLINIC HOSPITAL
Languages: English/Spanish
(216) 445-0150
9500 Euclid Ave Taussig Cancer Institute
Read MoreThe relationship between pathologic nodal disease and residual tumor viability after induction chemotherapy in patients with locally advanced esophageal adenocarcinoma receiving a tri-modality regimen.
McNamara, M. J.,Rybicki, L. A.,Sohal, D.,Allende, D. S.,Videtic, G. M.,Rodriguez, C. P.,Stephans, K. L.,Murthy, S. C.,Raja, S.,Raymond, D.,Ives, D. I.,Bodmann, J. W.,A...; J Gastrointest Oncol. 2016 Apr 02.
See more >>Predicting early mortality in resectable pancreatic adenocarcinoma: A cohort study.
Sohal, D. P.,Shrotriya, S.,Glass, K. T.,Pelley, R. J.,McNamara, M. J.,Estfan, B.,Shapiro, M.,Wey, J.,Chalikonda, S.,Morris-Stiff, G.,Walsh, R. M.,Khorana, A. A.; Cancer. 2015 Feb 14.
See more >>Antiplatelet antibodies in oxaliplatin-induced immune thrombocytopenia.
Mittal, K.,McNamara, M. J.,Curtis, B. R.,McCrae, K. R.; JRSM Open. 2014 Jul 25.
See more >>